Menu
Logo

AL Amyloidosis



I See AL amyloidosis


Welcome to I See AL amyloidosis, a dedicated resource to help healthcare practitioners find the latest information about the signs, symptoms and diagnosis of AL amyloidosis.


What is AL amyloidosis?

AL amyloidosis is a rare and fatal disease characterised by misfolded proteins that produce abnormal light chains.[1] These chains may form amyloid fibrils, which aggregate and deposit in multiple vital organs.[2]

Impact on multiple organs[2]

ig-heart
ig-kidneys
ig-liver
ig-nerves
gi-tract

AL amyloidosis is also clinically evident in soft tissues in 17% of cases.[2]

Background

AL amyloidosis impacts the lives of tens of thousands of patients each year.[3] It is not easy to identify. Improved disease awareness is one of the critical components of achieving earlier diagnosis and improved prognosis.[1][3]

1Year

Patients present with a range of symptoms. Proper diagnosis commonly takes ≥1 year after initial presentation.[3]

thirdOfPatients

One third of patients may visit ≥5 different physicians before diagnosis.[3]

AL AMYLOIDOSIS IS A LIFE-THREATENING DISEASE, AND A DELAYED DIAGNOSIS IS DIRECTLY LINKED TO POORER OUTCOMES[1][2][3]

Early diagnosis may lead to improved prognosis[^1]:

Once suspected, AL amyloidosis can be diagnosed. Diagnosis starts with awareness and requires collaboration across specialties. When healthcare professionals recognise the symptoms better and work together, they can impact outcomes in AL amyloidosis.

Currently the consensus is to treat patients with plasma cell–directed therapies, with the goal of reducing light-chain production that can help preserve organ function and ultimately improve prognosis.[1][3][4][5]

Watch the expert video

Dr Vaishali Sanchorawala (haematology/oncology) and Dr Omar Siddiqi (cardiology) highlight the need to recognise the symptoms of AL amyloidosis early.

Learn about recognising the specific symptoms of AL amyloidosis depending on your specialty

Other blood cancer conditions

I see Waldenström’s macroglobulinemia (WM)

Up-to-date information around identifying, diagnosing and treating WM.

I See mantle cell lymphoma (MCL)

Current advice regarding the diagnosis and treatment of MCL.

I See acute myeloid leukaemia (AML)

Most recent guidance into diagnosing and treating acute myeloid leukaemia.

ISBC

A dedicated online resource for healthcare professionals to learn about the diagnosis and management of rare haematological malignancies: AL amyloidosis, Waldenström's macroglobulinemia, mantle cell lymphoma and acute myeloid leukaemia.

Download this information on AL amyloidosis

CP-255639 - September 2021